BrainStorm Cell Therapeutics Inc. Announces New Shareholders Conference Call Date to Discuss Upcoming Positive Developments

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has rescheduled its previously planned shareholders conference call. The call will be held on Monday, January 14, 2013 at 8:00 a.m. EST in Hebrew and at 8:45 a.m. EST in English. The company’s senior management team will discuss some significant positive company developments to be released shortly.

Back to news